V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010358 | 190007568 | 1.9 | 24.5 | null | 2020-07-06 | 2020-07-07 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100958431 |
| 190010360 | 190007569 | 1.85 | 29.5 | null | 2019-11-17 | 2019-11-23 | Methotrexate High Dose (3g/m2) | 01 | null | MAP | 100086863 |
| 190010375 | 190007570 | 1.13 | 13.2 | Palliative (P) | 2021-11-28 | 2021-11-29 | Methotrexate Intermed dose (1g/m2) | 02 | N | METHOTREXATE | 100484423 |
| 190010378 | 190007571 | 1.66 | 87.7 | Curative (C) | 2021-01-25 | 2021-08-31 | Brentuximab | 02 | null | STS NON-RHABDO EPSSG 2005 VDC/IE | 101604181 |
| 190010413 | 190007572 | 0 | 30.8 | 03 | 2018-04-14 | 2018-11-23 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101790227 |
| 190010414 | 190007573 | 0 | 89.8 | null | 2015-08-18 | 2017-07-14 | DOCETAXEL + GEMCITABINE | 2 | Y | DOCETAXEL + GEMCITABINE | 100303566 |
| 190010417 | 190007574 | 0 | 47 | Palliative (P) | 2019-01-19 | 2019-02-16 | Carboplatin + Etoposide iv&po | 02 | N | EURAMOS TRIAL | 100684600 |
| 190010453 | 190007575 | 1.68 | 79.8 | Curative (C) | 2019-01-12 | 2020-06-30 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100633818 |
| 190010459 | 190007576 | 0 | 43 | null | 2018-05-29 | 2018-12-15 | OST Euramos 1 Closed Trial - M | 02 | null | CARBOPLATIN + ETOPOSIDE | 101317669 |
| 190010462 | 190007577 | 1.65 | 94.85 | null | 2016-07-05 | 2017-01-25 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101564620 |
| 190010473 | 190007578 | 0 | 31.9 | Adjuvant (A) | 2021-01-02 | 2021-01-02 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 100010762 |
| 190010480 | 190007579 | 1.74 | 115 | null | 2017-08-26 | 2017-09-28 | IFOSFAMIDE + PACLITAXEL | 99 | Y | TRIAL | 101828403 |
| 190010500 | 190007580 | 0 | 47.8 | Palliative (P) | 2016-04-07 | 2018-12-08 | CARBO + FLUOROURACIL | null | null | CISPLATIN | 101662835 |
| 190010509 | 190007581 | 1.81 | 61.7 | Curative (C) | 2016-11-30 | 2018-02-18 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100277654 |
| 190010510 | 190007582 | 1.63 | 91 | Palliative (P) | 2018-03-26 | 2018-03-29 | ECX | 02 | null | CISPLATIN + CYTARABINE | 101045967 |
| 190010523 | 190007583 | 1.79 | 87.2 | null | 2016-02-21 | 2016-09-18 | NIVOLUMAB | 02 | N | VAI | 100632183 |
| 190010535 | 190007584 | 1.47 | 64 | Palliative (P) | 2017-12-29 | 2018-02-01 | OCTREOTIDE | 02 | null | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 101646211 |
| 190010544 | 190007585 | 0 | 20.5 | Palliative (P) | 2019-12-01 | 2020-01-19 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | DOXORUBICIN + METHOTREXATE | 100047691 |
| 190010554 | 190007586 | 0 | 63.1 | Adjuvant (A) | 2018-07-07 | 2019-01-05 | OST Euramos 1 Closed Trial - M | 02 | null | NIVOLUMAB | 101448429 |
| 190010589 | 190007587 | 0 | 37.3 | Palliative (P) | 2016-06-08 | 2017-02-19 | Docetaxel | 02 | N | MAP | 100945629 |
| 190010593 | 190007588 | 0 | 43.8 | Adjuvant (A) | 2020-09-22 | 2020-09-25 | GC Int Guide Excranial GermCell JEB | 02 | null | TRIAL | 101788187 |
| 190010596 | 190007589 | 1.65 | 58 | Palliative (P) | 2018-03-26 | 2018-10-25 | null | 02 | N | CYTARABINE + FLUDARABINE | 100167309 |
| 190010597 | 190007590 | 0 | 43 | Adjuvant (A) | 2017-08-02 | 2018-03-19 | Cyclophosphamide + Vincristine | 02 | null | OST IE | 100364039 |
| 190010598 | 190007591 | 0 | 0 | Curative (C) | null | 2018-04-22 | OST Euramos 1 Closed Trial - M | null | null | OST M | 101068976 |
| 190010604 | 190007592 | 0 | 11.4 | Curative (C) | 2017-09-19 | 2017-09-19 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | null | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101695167 |
| 190010621 | 190007593 | 1.77 | 58.5 | null | 2016-09-04 | 2016-09-06 | DHAP | 02 | N | STS NON-RHABDO EPSSG 2005 VCY | 100869513 |
| 190010631 | 190007594 | 0 | 62 | null | 2021-02-25 | 2021-03-19 | OST Euramos 1 Closed Trial - M | null | null | OST M | 101376355 |
| 190010645 | 190007595 | 1.7 | 82.6 | Palliative (P) | 2022-02-28 | 2022-03-01 | Cisplatin + Doxorubicin | 01 | N | MAP + MIFAMURTIDE | 101482072 |
| 190010650 | 190007596 | 1.77 | 72 | Curative (C) | 2018-07-12 | 2018-07-12 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100561190 |
| 190010677 | 190007597 | 1.72 | 59 | Palliative (P) | null | 2019-06-11 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101071807 |
| 190010685 | 190007598 | 0 | 27.5 | Palliative (P) | 2016-10-28 | 2017-04-24 | Etoposide + Ifosfamide (3 days) | 01 | N | ETOPOSIDE + IFOSFAMIDE | 101159852 |
| 190010710 | 190007599 | 0 | 21.4 | Curative (C) | 2022-01-29 | 2022-04-18 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101002130 |
| 190010719 | 190007600 | 1.46 | 53 | Palliative (P) | 2018-09-06 | 2018-10-05 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100144097 |
| 190010729 | 190007601 | 0 | 0 | null | 2017-07-07 | 2017-08-03 | Capecitabine + Oxaliplatin 21day | 02 | null | METHOTREXATE HIGH DOSE | 100411559 |
| 190010739 | 190007602 | 1.75 | 78.4 | Palliative (P) | 2018-03-19 | 2018-03-25 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | EURO-EWING | 100569513 |
| 190010755 | 190007603 | 1.72 | 57 | Curative (C) | 2018-07-10 | 2018-08-02 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101847115 |
| 190010800 | 190007604 | 0 | 65 | null | 2016-04-21 | 2017-07-07 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100086834 |
| 190010837 | 190007605 | 1.68 | 47 | null | 2019-08-18 | 2019-08-23 | EW EuroEwing 2012 Arm A/B BuMEL | 01 | N | OST IE | 101586453 |
| 190010850 | 190007606 | 1.75 | 38.9 | Curative (C) | 2018-09-05 | 2019-02-25 | EW EuroEwing 2012 Arm A VAI | 02 | null | NB HRNBL-1 COJEC IND COURSE B | 100033451 |
| 190010853 | 190007607 | 1.67 | 69.3 | null | 2020-03-15 | 2020-05-08 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 100377460 |
| 190010859 | 190007608 | 1.8 | 95 | Curative (C) | 2020-06-16 | 2021-01-14 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100146635 |
| 190010881 | 190007609 | 1.79 | 49.1 | Curative (C) | 2021-06-17 | 2021-06-17 | EW EuroEwing 2012 Arm B IE | 01 | null | EW EUROEWING 2012 ARM B IE | 101581794 |
| 190010887 | 190007610 | 1.74 | 77.45 | null | 2017-12-24 | 2018-05-10 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101753075 |
| 190010888 | 190007611 | 0 | 55.5 | Palliative (P) | 2017-05-23 | 2017-06-20 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101759564 |
| 190010903 | 190007612 | 1.61 | null | Palliative (P) | 2019-06-27 | 2019-07-01 | EW EuroEwing 2012 Arm B VDC | null | null | NB HRNBL-1 BUMEL MAT | 101580678 |
| 190010905 | 190007613 | 1.77 | 63.5 | Neo-adjuvant (N) | null | 2017-06-14 | Atezolizumab | null | null | EW EUROEWING 2012 ARM B CE | 100829799 |
| 190010928 | 190007614 | 1.8 | 92.3 | Curative (C) | 2021-11-10 | 2021-12-11 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101391675 |
| 190000680 | 190007615 | 1.55 | 93 | null | 2016-12-12 | 2017-02-28 | CARBO + FLUOROURACIL | 02 | null | TRIAL | 101671483 |
| 190000808 | 190007616 | 1.6 | 57.75 | null | 2021-09-22 | 2021-10-07 | CABOZANTINIB | 02 | null | EURAMOS TRIAL | 101186648 |
| 190002742 | 190007617 | 1.82 | 90 | Neo-adjuvant (N) | 2019-09-09 | 2019-09-09 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100678585 |